# Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033

> **NCT00376285** · PHASE1 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Obesity

## Interventions

- **DRUG:** CP-742,033
- **DRUG:** Fenofibrate

## Key facts

- **NCT ID:** NCT00376285
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376285, "Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00376285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*